Genomics Research

 
Stock Quotes for Genomics Research top ^
  • Industry: Diagnostics & Research
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Speculative Growth
Sign-up for ghdx investment picks
  • Industry: Diagnostics & Research
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Speculative Growth
Sign-up for ghdx investment picks
  • Industry: Diagnostics & Research
  • Sector: Healthcare
  • Stock Style: Small Value
Sign-up for rosg investment picks

 
ETF Quotes for Genomics Research top ^
  • Holdings: Idenix Pharmaceuticals Inc , Illumina Inc , Gilead Sciences Inc , Waters Corp , Amgen Inc ,
  • Morningstar Rating: 3 Stars
Sign-up for pbe investment picks

 
News Articles for Genomics Research top ^
Lung Biotechnology Also Makes $50M Equity Investment in SGI LA JOLLA, Calif.
Sign-up for Synthetic Genomics Inc. Signs Collaborative Research and Development Agreement with Lung Biotechnology Inc., a Subsidiary of United Therapeutics Corporation, to Develop Humanized Pig Organs to Revolutionize Transplantation Field investment picks
Centralized database of gene-based tests enables easy access to information, improves transparency REDWOOD CITY, Calif.
Sign-up for Genomic Health's Oncotype DX® Becomes First Multi-Gene Test for Cancer Management To Be Included in National Institutes of Health's (NIH) Genetic Testing Registry investment picks
New Analysis Suggests Oncotype DX Predicts Recurrence Risk After Prostatectomy Regardless of Post-Surgery Treatment REDWOOD CITY, Calif.
Sign-up for Genomic Health Announces Data Reinforcing Robustness of Oncotype DX® Prostate Cancer Test at 2014 American Urological Association (AUA) Annual Meeting investment picks
REDWOOD CITY, Calif.
Sign-up for Genomic Health to Present at Two Upcoming Investor Conferences investment picks
2014/5/6
13% Increase in Test Volume and 7% Increase in Product Revenue Compared to Prior Year Global Adoption Continues to Grow with Multiple Significant International Milestones 9 Abstracts Accepted for Presentation at ASCO Highlighting Progress Across Breast, Colon, Prostate and Renal Programs Conference Call Today at 4:30 p.m. ET REDWOOD CITY, Calif.
Sign-up for Genomic Health Announces First Quarter 2014 Financial Results and Business Progress investment picks
The Mantle-Cell and Follicular Lymphoma Tests Were Validated In Research Collaborations With Memorial Sloan Kettering and Have Been Successfully Licensed Under Both CLIA and New York State Regulations Tests Address Over One-Third of non-Hodgkin Lymphomas And Will Be Made Available As Part of Comprehensive Testing Programs To Provide Targeted Diagnostic And Prognostic Information RUTHERFORD, N.J., May 5, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based diagnostics, today announced it has received CLIA and New York state approvals for clinical use of its proprietary mature B-cell neoplasm array, or MatBA ® for Follicular Lymphoma (MatBA ® -FL) and Mantle-Cell Lymphoma (MatBA ® -MCL). Both tests further extend the portfolio in hematologic cancers being developed by CGI and both were developed and validated via a research collaboration with Memorial Sloan-Kettering Cancer Center.
Sign-up for Cancer Genetics Launches Genomic Tests for Follicular Lymphoma and Mantle Cell Lymphoma - Further Extends Unique Position in Targeted Testing of Hematologic Cancers investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Genomics Research
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Genetic Research  |  Next: Gentiva Health Services